Literature DB >> 23125220

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

Li-Yi Zhang1, Victor Ho-Fun Lee, Alissa Michelle Go Wong, Dora Lai-Wan Kwong, Ying-Hui Zhu, Sui-Sui Dong, Kar-Lok Kong, Juan Chen, Sai-Wah Tsao, Xin-Yuan Guan, Li Fu.   

Abstract

Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer with significantly high prevalence in Southern China. Unlike other head and neck cancers, mutations or deletions of tumor suppressor genes in NPC are not common. Recently, downregulation of tumor suppressor genes expression by microRNA (miRNA) is increasingly recognized as an important mechanism of nasopharyngeal tumorigenesis. In this study, we reported that microRNA-144 (miR-144) was frequently upregulated in NPC specimens and cell lines. Repression of miR-144 significantly decreased cell proliferation, clonogenicity, migration, invasion and tumor formation in nude mice, while restoring miR-144 in miR-144-attenuated NPC cells exhibited a strong tumorigenic role. Further, we found that miR-144 was inversely correlated with the tumor suppressor gene phosphatase and tensin homolog (PTEN) in NPC specimens and cell lines, and then we identified PTEN as a direct target of miR-144 in NPC cell lines. PTEN downregulation in miR-144-attenuated cells could increase cell growth, migration and invasion. Mechanistic investigations revealed that miR-144 suppressed the expression of PTEN to increase the expression of pAkt and cyclin D1 to promote G(1)-phase transition and decrease E-cadherin to promote migration and invasion. Taken together, we provide compelling evidence that miR-144 functions as an onco-miRNA in NPC, and its oncoeffects are mediated chiefly by repressing PTEN expression to activate the PI3K/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125220     DOI: 10.1093/carcin/bgs346

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  90 in total

Review 1.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

2.  Circular RNA 0081146 facilitates the progression of gastric cancer by sponging miR-144 and up-regulating HMGB1.

Authors:  Qihua Xu; Bingling Liao; Sheng Hu; Ying Zhou; Wei Xia
Journal:  Biotechnol Lett       Date:  2021-01-26       Impact factor: 2.461

3.  Is miR-144 an effective inhibitor of PTEN mRNA: a controversy in breast cancer.

Authors:  Vahid Kia; Maryam Sharif Beigli; Vahedeh Hosseini; Ameneh Koochaki; Mahdi Paryan; Samira Mohammadi-Yeganeh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-21       Impact factor: 2.416

4.  miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4.

Authors:  Faheim Mushtaq; Jinping Zhang; Jiansheng Li
Journal:  Oncol Lett       Date:  2019-04-04       Impact factor: 2.967

5.  microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.

Authors:  Chin-Wen Chang; Hui-Chen Wu; Mary Beth Terry; Regina M Santella
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

6.  Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.

Authors:  Weiwei Liang; Zhiwei Xie; Weiling Cui; Yan Guo; Lijuan Xu; Jueheng Wu; Hongyu Guan
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-10       Impact factor: 4.553

7.  Comparison of miRNA and gene expression profiles between metastatic and primary prostate cancer.

Authors:  Kaimin Guo; Zuowen Liang; Fubiao Li; Hongliang Wang
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

8.  Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.

Authors:  Hongyu Guan; Weiwei Liang; Zhiwei Xie; Hai Li; Juan Liu; Liehua Liu; Lingling Xiu; Yanbing Li
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

9.  miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1.

Authors:  Xin Wu; Chang-Lei Cui; Wei-Lun Chen; Zhong-Ying Fu; Xiang-Yan Cui; Xu Gong
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

10.  miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.

Authors:  Suna Zhou; Wenguang Ye; Yanjun Zhang; Dequan Yu; Qiuju Shao; Jun Liang; Mingxin Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.